- Labcorp Patient Direct enables faster recruitment of Labcorp-tested COVID-19 patients
- Access to patient samples and data on Labcorp-tested COVID-19 patients
- Laboratory assays and expedited assay validation
COVID-19 Testing & Research
Whether you are developing a COVID-19 assay, a vaccine to prevent patients from getting COVID-19, an antiviral or a treatment to mitigate the severe immunological response (cytokine storm) associated with COVID-19, we can partner with you to provide critical drug development and diagnostic services to address the pandemic.
COVID-19 Research Development & Testing
Space
Apply the Labcorp Advantage in the Fight Against COVID-19. No other organization can offer this breadth of coordinated services or match our global reach
-
Drug development & diagnostics capabilities
-
Global vaccine & infectious disease experience
- Critical care inpatient and outpatient experience
- Experience with more than 700 infectious disease trials and more than 150 vaccine trials in the last 5 years (see central laboratory testing and clinical trials)
- Experience in more than 250 vaccine and antiviral studies in the last 5 years (see nonclinical testing)
-
Dedicated COVID-19 response teams
- Mobilized, committed COVID-19 study project teams
- Nonclinical through Phase IV drug development allows us to reduce transition time between studies
- Cross-functional, experienced, rapid-response team meets daily to focus on client requests/ideas
-
Relationships with regulatory agencies
- Frequent interactions with MHRA and FDA on new development programs
- Experience interacting with the FDA CTAP group
-
Medical device & Diagostics Experience
- Experience with more than 500 Medical Device & Diagnostic studies and over 5000 investigator sites in the last 5 years
- Breadth of contract research offerings includes the entire product development lifecycle from regulatory consultation to preclinical, clinical and commercialization services
Connect with our COVID-19 Response Team
Contact Us